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ABSTRACT  Interferon  production  can  be  stimulated  by  a  great  variety  of
microbial  and  nonmicrobial  agents  other  than  viruses.  The  nonmicrobial
inducers  can  be divided  into polyanions,  mitogens,  and  a miscellaneous  cate-
gory  including  the various  endotoxins  and  antibiotics. The  polyanions appear
to require a stable, high  molecular weight backbone  and a high  density of free
anionic  groups  whether they  are polynucleotides,  plastics,  or  polysaccharides.
Mitogen-induced  interferon  appears  to  be  but  one  of a  constellation  of sub-
stances  produced  following  lymphocyte  transformation.  The  process  of trans-
formation  can  be  stimulated  either  by  specific  immune  recognition  or  non-
specifically  by  phytohemagglutinin.  Synthetic  polynucleotide  inducers  are
active;  the  thermostable,  double-stranded  RNA's  are  much  more  active  than
the  double-stranded  DNA's  or  1-,  3-,  or  4-stranded  RNA's.  Some  success  has
been obtained with potentiation of nucleotide  inducers through  the use of poly-
cationic  substances,  complexing  with  a  polysaccharide,  concurrent  adminis-
tration  of  a  metabolic  antagonist,  or  substitution  of  phosphate  by  thiophos-
phate  in the  polynucleotide  backbone.  The  stages  in the  interaction  of inter-
feron stimulating  RNA and cells can  be divided  into three  steps: first,  binding
to cell  surface,  next,  a temperature  dependent  "recognition"  step,  and  finally,
degradation and utilization of monomers  in cellular RNA  synthesis; the critical
recognition site has not yet been determined. The vast majority of cell-associated
polynucleotide  remains  at  the  surface  of  the  cell.  Information  from  animal
models  resembling  human  diseases  suggests  that  certain  of  these  nucleotide
inducers  may  have clinical  usefulness  in therapy or prophylaxis.
INTRODUCTION
In  1964  interferon  was  observed  in the  serum  of chickens  that had  been  in-
jected  intravenously  with  Brucella abortus by Youngner  and  Stinebring  (1).
This finding indicated that substances  other than viruses  could lead to inter-
feron  stimulation.  Youngner  has  discussed  the  observations  with  nonviral
interferon inducers  of microbial origin earlier in this Symposium.
This  presentation  will  focus  on  nonmicrobial  inducers,  in  particular  on
synthetic  inducers  from  which  one  can  draw  conclusions  as  to  the  critical
structural  requirements  for this process.  The RNA  inducers  have  received  a
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great deal of attention recently as they are the most potent on a weight basis
and  are  among  the  least  toxic  presently  available  as well  as  perhaps  most
resembling  the natural stimuli to interferon production during virus infection.
CLASSES  OF  INDUCERS
A  classification  of  nonviral  agents  stimulating  interferon  production  is
presented  in Table  I.  The microorganisms  which  are  capable  of interferon
induction  are  intracellular  parasites  in  the  main,  whereas  another  large
group  of  interferon  inducers  are  the  polyanions  (the  multi-stranded  RNA
polynucleotides,  the  plastics,  and  the  polysaccharides).  So  far,  wherever  it
TABLE  I
INTERFERON  STIMULATION  BY  NONVIRAL  AGENTS
Agent  Critical features
Microorganisms  (bacteria,  protozoa,  etc.)  Intracellular  parasites  (replication  not neces-
sary)
Polynucleotides  (multi-stranded  RNA's)  (Stable high molecular weight  backbone
Plastics  (pyran  copolymer,  polyacrylic  IHigh  density  of  free  anionic  groups  (car-
acid,  polyvinyl sulfate,  etc.)  1 boxylates,  phosphates,  thiophosphates,
Polysaccharides  (mannan phosphate,  dex-  sulfates)
tran  phosphate,  oxidized  amylose etc.)
Mitogens  (specific  antigens  or nonspecific  Active  in  cell  lymphocyte  transformation
agents:  e.g.,  phytohemagglutinin)  (RNA  and  DNA  synthesis  and  other
effector  substances  released)
Miscellaneous  (endotoxins,  antibiotics)  Narrow therapeutic  ratio  (possibly  concomi-
tant toxic  cell  destruction)
has  been  examined,  the  critical  features  for  the  activity  of  the  polyanions
appear  to  be a stable, high molecular  weight backbone  and a high density of
free  anionic  groups which may  be phosphates,  thiophosphates,  carboxylates,
or sulfates  (2-4).  There  are,  of course,  other structural  features  required for
interferon-inducing  capacity,  as  not  all  polyanions  with  a  high  molecular
weight,  high  charge  density,  and  structural  stability  are  active,  e.g.,  poly-
galacturonic  acid  (4)  and  polyaspartic  and  polyglutamic  acids  (2)  are  not
active.
A  interesting  group  of  polysaccharide  derivatives  recently  described  by
Claes  and  his  associates  (5,  6)  are  the  polyacetal  carboxylic  acids.  These
polycarboxylates  are formed  by a two step  oxidation of polysaccharides  with
chlorite.  The  backbone  of these  polyanions  contains  acetal  (-C--C--O-
I  I  I  I  I  I
C-O-)  instead  of  the  ethylene  (-C--C--C--C-C-)  linkages  of  the
plastics.  They  are markedly  less  tox  I  I  the  Ic polycarboxylates  and
plastics.  They  are  markedly  less  toxic  than  the  plastic  polycarboxylates  and
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have  a  therapeutic  ratio  in  the  range  of  300-500,  and  they  had  a  more
transient  protective  effect  in  various  animal  models  against  virus  infection
than did the plastic polycarboxylates.  This suggests that the acetal-containing
backbone  is more  easily  biodegraded  than  the  plastics.  The requirement  of
free  anionic  charges  for  antiviral  activity  was  established  for  this  series  of
compounds  (as it  had been  shown for pyran  copolymer  [2]  and  polyacrylic
acid [3]),  in that the partially oxidized polysaccharides  were of lesser activity,
and the nonoxidized parent compounds  were inactive.
Another  interesting  polysaccharide  shown to be active by De Somer et al.
(3)  was  a sulfated polysaccharide  extracted  from seaweed.  The activity  may
be related to the recently observed double-stranded  helical configuration  of a
seaweed-derived  sulfated  polysaccharide  (carrageenan)  (7).
In  addition  to  the microorganisms  and  the polyanions,  another  group  of
interferon  inducers  are  the  mitogens.  The  mitogens  have  been  most  well
studied in vitro, and they include both specific antigens and nonspecific agents
such  as  phytohemagglutinin.  The  interferon  is  produced  by  lymphocytes
prior  to their transformation  (8).
The  fourth class  of interferon  inducers  is  grouped  somewhat  arbitrarily.
Here belong the various endotoxins  (9,  10),  together with the two antibiotics,
cycloheximide  (11)  and  kanamycin  (12),  which have  been shown  to induce
interferon.  These  inducers  were  active  in  the  whole  animal  with  a rather
narrow  therapeutic  ratio.  Endotoxin  has  also  been  found  to  be  active  in
peritoneal  macrophages  (13,  14)  and in leukocytes  (14,  15)  in releasing small
amounts of interferon,  but it has been quite inactive in all other cells. As these
macrophages and leukocytes only represent explants and are not purified cell
preparations,  it is  possible  that here,  as in  the whole  animal,  there may be
multiple cell types involved in this activity.
Effector  substances  are  released  during  lymphocyte  transformation  and
possibly  are  involved  in  delayed  hypersensitivity,  homograft  reaction,  and
other  forms of cell-mediated  immunity.  The effector  or mediator  substances
which  are produced  during lymphocyte  transformation  (16)  are  as follows:
interferon, lymphotoxin,  migration inhibitory factor, chemotaxic factor,  skin-
reactivity  factor,  and  mitogenic  factor.  The  biological  significance  of Whe-
elock's  finding  of phytohemagglutinin  stimulation  of  interferon  production
from lymphocytes  (8) was not clear initially. With the discovery of these other
activities  produced  during  lymphocyte  transformation,  one  can  propose  a
more specific role for interferon.  It seems reasonable  to suggest that it acts  at
the site of virus infection to block further local  extension of the virus working
with  the  other  effector  or  mediator  subsances.  These  components  of  the
delayed  hypersensitivity  or  cell-mediated  immunity  system  appear  to  be
triggered during transformation,  each having a useful role in the inflammatory
response.  Lymphotoxin  acts  by  destroying  certain  cells;  the  migration  in-
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hibitory factor brings to the site of transformation macrophages whose phago-
cytic capacity is useful in dealing with the  foreign  materials;  the chemotaxic
factor  brings  polymorphonuclear  leukocytes  to the  infiltrate,  and the mito-
genic factor recruits other lymphocytes into the inflammatory filtrate  through
their transformation.  The skin-reactivity factor  is capable  of producing  many
of the  cellular  changes  of delayed  hypersensitivity  in  the  skin  within  a few
hours.  Only  interferon,  by virtue  of  its  low  molecular  weight  (18,000),  is
clearly differentiatable  from the other five activities  whose molecular weights
are all in the range of 70-80,000. The specificity to this inflammatory response
is  conferred  by  the  specific  immune  recognition  inherent  in  lymphocyte
transformation.  This  area  will  be  discussed  further  by Dr.  Lowell  Glascow
later  in  this  Symposium.
Green  and  his  associates  (17)  have  been  able  to  show  that  tuberculo-
protein,  diphtheria  toxin,  and  tetanus  toxin  will  cause  the  production  of
interferon from lymphocytes  if they  are obtained  from specific  sensitized  in-
dividuals. In addition,  Stinebring and Absher  (18)  have shown that, in BCG-
infected  mice,  injection  of tuberculo-protein  causes  a circulating  interferon
response  within  6  hr.  In collaboration  with Dr.  Lois  Epstein  we  have  also
observed  transformation-induced  interferon  produced  in vivo  in  the  mouse.
Low  levels  of  serum  interferon  were  observed  for  several  days  following
administration  of high  doses  of phytohemagglutinin.  However,  these  studies
may  only  be examining  "the  top of the  iceberg"  as  to the  extent  or role of
this  antiviral  effect.  It is  possible  that the  critical  amount  of interferon  or
other mediator  substances  being released  at the  site of virus infection,  either
at the port of entry or at the end  organ,  may be extremely low and yet quite
useful  to the host as a rapidly mobilizable antiviral  function.
The  requirements  for  activity  of  synthetic  polynucleotide  inducers  are
reviewed  in Table  II. Initial studies  by Isaacs  and his coworkers  in England
suggested  that foreign  polynucleotides  were  active  in  interferon  production
(19,  20),  but there  was  some  difficulty  in  reproducing  these  studies  in  his
TABLE  II
SYNTHETIC  POLYNUCLEOTIDE  INDUCERS
Inducer  Activity
Double-stranded  RNA  Very  active if strands  are complementary
Thermostability  is  important  as  reflected  in  Tm  >  60°C
necessary  for full activity
Salt,  pH,  and divalent  cation content all  may  alter Tm  and
activity
Other  unknown  factors  very  important
3-  or 4-stranded  RNA  Of  two  different  types  or a  single  type
Less  active  than  double-stranded  RNA's
Double-stranded DNA  Much less active than double-stranded  RNA's
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laboratory  (21).  However,  the studies of Hilleman  and  his  associates  (as re-
viewed in reference  22)  sharply focused  interest  on this area by clearly dem-
onstrating the importance of the double strand in polyribonucleotides in their
in vivo  and in vitro interferon-inducing  capacity.  These polyribonucleotides
were obtained from a wide variety of sources,  including natural  sources such
as  double-stranded  mammalian  viruses  (23),  bacterial  viruses  (24),  plant
viruses (25), and fungal viruses (26),  as well as synthetic RNA's enzymatically
polymerized in the laboratory by a variety of techniques (27). Activity has been
shown with both alternating  copolymers  (which form a base-paired,  double-
stranded  single molecule)  as  well  as with  homopolymer  pairs  (composed  of
two complementary  strands,  each of repeating  sequences of the same bases).
This work will be discussed in more detailed  by Dr. A. K. Field later in this
Symposium.
We have been  interested  in the  structural  requirements  for the activity  of
these synthetic polymers,  and our conclusions  to date are reviewed  in Table
II.  With  the  active  double-stranded  complexes,  it  appears  as  though  a
threshold degree of thermostability  is important in that complexes with a low
degree of stability are inactive, and that increasing this stability of the double-
stranded pair, either by changes in salt, pH, or divalent cation content, appears
to alter the stability and biologic activity in parallel (28). Interestingly enough,
certain chemical substitutions,  such as halogenation in the C5 position which
do not effect the stability (29), do not alter the activity (30),  whereas methyla-
tion of the N7 lowers the stability  (31)  and decreases  the activity  (30).  As we
survey the polymers studied in our laboratory  (28)  and elsewhere  (22,  30, 32),
the  thermostability  requirment  is  not adequate  to wholly  explain  the high
activity of certain double-stranded  RNA complexes. A similar conclusion was
reached  by Colby and Chamberlin  (32).  It is clear that other factors  in the
three-dimensional  structure of these polynucleotide complexes must be highly
critical in the interaction with the cell. These factors might be acting through
a variety  of means.  Either they act to promote the binding or penetration  of
the cell by the polymer,  or they may alternatively  act to promote the affinity
of the polymer for the interferon-triggering  site on or within the cell. A third
alternative  explanation  (which  will  be  discussed  below)  is  that  the three-
dimensional  structural  specificity  is  acting  through  the  specific  recognition
of nucleases which can destroy,  and thereby compete for,  the polynucleotide
before its interaction with the final receptor site. Therefore, this specificity can
be  either a positive one  in that those  molecules  which are recognized  act as
inducers,  or a negative system in that recognition by nuclease prevents certain
molecules from  acting as  inducers.  At present, there are no convincing  data
to  decide  among  these  possibilities.
One of the unknown factors  may be degree of packing  of negative charges
in  the polyanion.  It  is  known  that  the  homopolymer  pair  formed  of poly-
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inosinic  acid-polycytidylic  acid  (I:C) is  one  of the most  densely  packed  of
the  homopolymer  pairs  in  that,  when  it  is  annealed,  the negative  charges
are  closer  together  in  this  structure  than  in  the  less  active  polyadenylic-
polyuridylic  acid homopolymer pair (A: U)  (33).  A number of triple- or four-
stranded  RNA  complexes,  formed  from  either  two  different  homopolymer
types  or  from  a  single  self-aggregating  homopolymer  type  were  less  active
than  the  double-stranded  RNA's  (28).  In addition,  as has  been  stressed  by
Hilleman,  single-stranded  RNA's appear  to be inactive  (22).  Polyxanthylic,
polyinosinic,  and  polyguanylic  acids  each  tended  to  form  multi-stranded
complexes under the physiologic conditions usually employed in tissue cultures
and had a borderline activity in this form (28).  By altering the pH or divalent
cation  concentrations  one can  cause  polyadenylic  and cytidylic  acids  also to
shift  from  single-stranded  to  multi-stranded  complexes  (28)  and  to  become
active.  Double-stranded  DNA complexes  of a composition  similar  to that of
active double-stranded  RNA complexes are much less active  (4).  Exactly  how
this marked difference in activity  is achieved  is unclear.
POTENTIATION  OF  RNA  INDUCERS
Mechanisms  for potentiating the activity of polyribonucleotide  inducers have
been  recently evolved  (Table III). Almost 2 yr ago,  Dianzani  and his  asso-
ciates (34),  taking a lead from studies with infectious viral RNA's and DNA's,
observed  that DEAE-dextran  promoted  interferon-inducing  activity  of I:C
in tissue  culture. They observed that L cells would  only produce interferon  if
they were treated with DEAE-dextran in addition to I: C  (34).  Subsequently,
others  have  confirmed  this  finding  (35-37),  and  Colby  and  Chamberlin
studied  a  large  series  of  helical,  double-stranded  RNA  in  chick  embryo
fibroblasts  by using DEAE-dextran  to potentiate their antiviral activity (32).
DEAE-dextran increased interferon production in vivo with I: C in one study
(38)  but not in others.'
It is of interest that the kinetics of interferon production  are altered in cells
treated with DEAE-dextran when they are studied in vitro. Dianzani and his
associates  (34)  noticed  the peak  of interferon production  in  tissue culture  at
24 hr in cells treated with DEAE-dextran,  in contrast to observation  of earlier
interferon  production in other cell types  (35-37, 39) responding in the absence
of DEAE-dextran.  Billiau  and  his  associates  (40)  have  studied  a  variety  of
basic  substances,  including  methylated  albumin,  protamine,  neomycin,
histone,  streptomycin,  etc.,  all  of which  appeared  similar  to DEAE-dextran
in potentiating interferon  induction in vitro. Lampson and his colleagues  (41)
found  polyamines  (such  as  neomycin)  active  in  potentiating  the  antiviral
'De  Clercq,  E., M. R. Nuwer, and T.  C. Merigan.  1970.  The  role  of  interferon  in  the  protective
effect of a synthetic double-stranded  polyribonucleotide  against intranasal  vesicular stomatitis  virus
challenge  in mice.  J.  Clin. Invest. In press.
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activity of I:  C in primary rabbit kidney cells, but neomycin failed to demon-
strate  an enhanced  antiviral activity in  other cell lines or an enhanced  inter-
feron production or resistance to virus infection in the whole animal. Consider-
ing the complexity  of the whole  animal and the possible multiple interactions
between  polyanionic  and  polycationic  molecules,  it  is  not surprising  that in
vivo results are not reproducible.  DEAE-dextran  has been observed  to protect
I:C from nuclease  degradation  (42)  and has  increased  the  binding of radio-
labeled  I:  C  by cells  and  has also  increased  the  amount  of labeled material
seen within  cells  (37).  Lampson  et  al.  (41)  showed  that neomycin  increased
the  stability  of double-stranded  RNA,  but they were  unable to  demonstrate
increased  rates  of cell  binding for  double-stranded  RNA  in  the  presence  of
neomycin.
Fig.  1  presents  another  observation  which  we  have  made  in  regard  to
binding  of  radiolabeled  I:C  in  the  presence  of  DEAE-dextran.  We  have
TABLE  III
POTENTIATION  OF  NUCLEOTIDE  INDUCERS
Approach  Mechanism
DEAE-dextran  and related  compounds  Complex  protected  from  nuclease  degrada-
(methylated  albumin,  neomycin,  etc.)  tion or increased cell binding or penetration
Thiophosphate  analogues  Protected from nuclease degradation
RNA-polysaccharide  complex  Protected  from nuclease  degradation
Cycloheximide  and  actinomycin  Possibly  interference  with  synthesis  of inter-
feron repressor  (?)
noted microscopically  visible aggregates  of radioactive material on cells when
they are  treated with tritium-labeled  I:  C in the  presence  of DEAE-dextran.
It  appears  also that there is more uptake  or binding of the polyanion  to glass
under these circumstances.  These aggregates can be seen in areas where there
are  no  cells;  therefore,  this  effect  is  nonspecific.  On  the  other  hand,  it  is
possible  that these  aggregates  are more resisant  to  nuclease  degradation  and
that their presence on the surface or within the cell is a critical mechanism  for
the potentiation  of interferon  production.  It  is  important  to remember  that
in cells that respond to  I:  C in the absence  of DEAE-dextran,  no more inter-
feron  is made  with DEAE-dextran  despite the fact that more polynucleotide
is  bound  (37).  Perhaps in  certain  cells  the  presence  of  these  aggregates  is
useful.  In  others, the threshold for the  response is exceeded  under the normal
conditions  of  binding,  and  therefore  the  effects  of DEAE-dextran  are  not
necessary.
Our laboratory  has  also  been  interested  in  the  possibility  of potentiating
the  biologic  activity  of  the  synthetic  polyribonucleotides  and,  in  fact,  has
63  sINTERFERON  INDUCTION.  II
made  some  progress  in that  direction.  It  appears  difficult  to  obtain  both  a
uniform material  by  complexing  polyanions with polycations and  a uniform
in vivo delivery  of polycations  and polyanions  separately  to  cells.  Therefore,
we  looked  for  a  change  in  the  intrinsic  structure  of the  polyanion  (RNA)
which  would  potentiate  the activity.  Certain  changes  in the  RNA  structure
increase or decrease  the stability of the double-stranded  complex  (see above),
but there were no remarkable  changes in activity. Our analysis of the stability
studies  indicated  that any chemical  change  in the RNA  backbone  to  poten-
tiate their activity should not decrease  the affinity of one of the two strands for
FIGURE  1.  Radioautography  of  human  fibroblasts  incubated  with  I:C  and  DEAE-
dextran.
the  other.  However,  it would  seem  useful  to  heighten  the  resistance  of  the
inducer  to  break  down either  outside of or within  the cell,  the latter  having
been  demonstrated  with  radiolabeled  I  :C  (as  will  be  described  below).
Therefore,  we aimed toward blocking nuclease degradation  with the smallest
possible  change  in polynucleotide  structure.
It  came  to  our  attention  that Dr.  Fritz  Eckstein  (Max-Planck-Institute,
G6ttingen,  Germany)  was  synthesizing  thiophosphate  analogues  of  double-
stranded  RNA  (43,  44).  The general  structure can  be  seen  in  Fig.  2.  In  the
series  of compounds  that  Eckstein  was  then  working  with,  only  one  of the
oxygens  on the phosphate  (bridging  the sugar moieties in the RNA backbone)
was substituted with sulfur, but this was carried out throughout the polynucle-
otide backbone.  This minimal change in structure was not associated with any
significant  change  in  stability  as  is  demonstrated  by the  fact  that the  thio-
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phosphate anlogues,  poly r(A-Us)  and poly r(As-Us),  and their parent  com-
pound,  poly r(A-U)  (alternating  copolymer  of riboadenylic  and ribouridylic
acid),  showed  an  identical  Tm  (thermal  transition  midpoint)  (43,  44).  The
thermal  transition  midpoint  assesses  the  point  at which  the  polunucleotides
change  from  helical  to random  coil  structure  and  can  be measured  with  a
high  degree  of  accuracy  under  any  given  salt  conditions.  However,  this
modest  change  (substitution  of sulfur for oxygen  in the  phosphate  linkages)
produced  a  major  change  in  sensitivity  to  several  different  nucleases  (44).
All of these nucleases were markedly less active  on the RNA analogue than on
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FIGURE  2.  Chemical  structure  of a polyribonucleotide  with alternating  base  sequence
with and  without thiophosphate  groups substituted  for phosphate groups.
the addition of a single shell of electrons  on one atom out of each  of the sub-
units  of  this  macromolecule.
When the  thiophosphate-substituted  polynucleotides  were  studied  for their
ability  to  produce  resistance  to  virus  infection  in  tissue  culture,  they  were
potentiated  by several  orders  of magnitude  (45).  We also found  them more
potent on a weight basis  in  inducing interferon  both in tissue  culture and in
vivo  (45).  The potentiation  of the  interferon-inducing  capacity  is  most likely
due  to  increased  resistance  to  nucleases  within  cells  with  the  specificity  of
pancreatic  ribonuclease.  Levy and his associates pointed out that the  nuclease
activity of the  serum may  be involved  in  the interferon  inducing activity  of
polynucleotides.2 The thiophosphates  showed an increased resistance  to serum
2 Norlund, J. J.,  S. M.  Wolff,  and H.  B.  Levy.  1970.  Inhibition  of biological  activity of poly I:  poly
C  by human plasma. Proc. Soc. Exp. Biol. Med. 133:439.
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inactivation  when compared to their parent compounds  as measured by  their
ability to confer cellular resistance  to virus infection  in vitro.3 The  increased
resistance  to serum closely  paralleled  the decreased  sensitivity  to degradation
by pancreatic ribonuclease and the increased capacity to induce interferon and
resistance  to virus infection  (45).3 Therefore,  we  feel it is of great importance
to explore  the results with thiophosphates  in animal models in regard to po-
tential  usefulness in clinical  medicine.  We are  currently  looking for the most
active congener  in this  series.  We then plan  to produce  larger quantitites  of
this material in order to determine whether it has a more favorable therapeutic
ratio in animal models  against virus infection when  compared to  their parent
compounds.  As  we  have  observed  a  somewhat  longer  period  of  interferon
production with these analogues  in tissue culture3 , it is possible that they will
give a more prolonged period of antiviral protection in animal models as well
as  being more active  on a weight basis.
To  return  to Table  III, Goore  and  his  associates  (46)  have  recently  dis-
covered an RNA-polysaccharide  complex which they obtained  from a fungus
of the Cunninghamella species.  It  appears  active in producing resistance  to virus
infection  in  cells  in tissue  culture  and animals  on the  basis  of nuclease  resis-
tance conferred on the RNA by complexing with a polysaccharide.  They were
able  to  demonstrate  interferon  production  with  a  polysaccharide  RNA
complex  in rabbit kidney cells,  and  they  found  that  the  complex  was  much
more active in producing  both interferon  and antiviral protection  than either
of its components.  When they  studied  the melting  curve  of the  RNA in the
complex  in  a  variety  of  salt  concentrations,  they  found  that there  was  no
evidence  of a sharp  thermal  transition,  and  they interpreted  this  to  indicate
that  this  RNA  was  of a  single-stranded  variety  and  active  in  interferon  in-
duction in tissue culture, because the polysaccharide protected it from nuclease
degradation.  This complex  is  of fundamental  interest  as  it has not been  re-
ported  in any other context  and as  yet has no role  in the metabolism  of the
organism  from which  it is  obtained.  Alternatively,  it may  be an  artifact  of
isolation  of  RNA  from  these  particular  cells  since  the  complex  may  form
through  nonspecific  association  of  RNA  with  a  cellular  polysaccharide
component.
A fourth mechanism  which  has  been  demonstrated  for  potentiating  inter-
feron production  by polynucleotides  both in vitro and in vivo  is the  adminis-
tration of proper doses and at a proper  timing of certain metabolic  inhibitors
such as actinomycin  (47)  or cycloheximide  (48, 49).  These studies,  which will
be reviewed  by Vilcek  in this  Symposium,  have  demonstrated  that  either  in
the  mouse  or  in tissue culture,  these metabolic  antagonists  increase  the  pro-
3 De Clercq,  E.,  F.  Eckstein,  H.  Sternbach,  T.  C. Merigan. The antiviral  activity  of thiophosphate
substituted polyribonucleotides  in vitro and  in  vivo.  In  preparation.
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duction  of interferon  when  given  together  with I:C  in vitro  (47,  49)  or  in
vivo  (48).  It has been interpreted  that these  agents  are  acting by interfering
with the synthesis of an endogenous inhibitor of interferon formation  (47, 49).
The main return from these studies of the effect of antibiotics and lead acetate
(50)  on the  interferon  induction by polynucleotides  is insight  into the mech-
anism  of  interferon  induction  rather  than  a  practically  useful  augmented
response.
For example,  the studies  outlined  in Table IV suggest  that the postulated
inhibitor  or  repressor  of interferon  induction  by  double-stranded  synthetic
RNA has no effect on an RNA virus induction of interferon. 4 Full yields of the
TABLE  IV
NONVIRAL  AND  VIRAL  INTERFERON  RESPONSE  IN
DUALLY  INDUCED  CELL  CULTURES*
Interferon




0-8  154  <5  240
8-23  8  606  765
0-8  135  <5  280
(Actinomycin  D pretreated)
8-24  30  34  34
(Puromycin  present)
* Cell monolayers  were incubated  for  1 hr at 37°C with  either control  media  or NDV  as indi-
cated.  After  this  time,  the  cell supernatants  were  replaced  with either  I:C  (50 tpg/ml)  or  con-
trol  media.  The fluids  were  then  collected  after  the indicated  intervals  and  assayed  for  inter-
feron.
early  interferon  stimulated  by I:C and  the late interferon  induced  by NDV
were  produced  in  cell  cultures  undergoing  dual  stimulation.  Hence  the
presence of the postulated  repressor  in cells did not block  the  NDV stimula-
tion while  it functioned  to turn  off synthetic  RNA  production  of interferon.
Verification  that the  first peak  was  entirely due to I:C  and that the  second
was due to NDV was achieved  through the use of actinomycin D and puromy-
cin,  respectively.  Actinomycin  failed  to  block  the  first round  of interferon,
whereas  puromycin  blocked  the  second.  The dose  of both  drugs  employed
was  selected  on  the  basis  of previous  studies  which showed  them  to  inhibit
NDV production  without effecting  yields from I:C  (14).
4Bausek,  G.  H.,  and  T.  C.  Merigan.  Simultaneous  viral  and  non-viral  interferon  induction  in
human  cell  cultures.  Proc. Soc. Exp. Biol. Med. 133:982.
67 INTERFERON  INDUCTION.  II
CELL  INTERACTION  WITH  SYNTHETIC  RIBONUCLEO-
TIDES
Our  conception  as  to  the  stages  in  the  interaction  of  interferon-inducing
RNA  and  cells  is  as  follows:  (a)  binding  to  cell  surface,  (b)  temperature
dependent recognition  step, and  (c) degradation  and utilization  in cell RNA
synthesis.  By exposing  cells  to RNA  in  the cold,  thereby  arresting  events  at
the binding  step  which  appears  to  be  an  electrostatic  nonenergy-requiring
step,  we  are  able  to  separate  this  step  from  a  second  step.  If the  cells  are
exposed  to the enzyme  ribonuclease after binding the RNA,  this RNA will be
destroyed  while  it  is still  at the cell  surface.  Thereby  the biological  effect  of
the RNA on the cells  will be blocked.  However,  if the cells are warmed up to
38°C for  1-2 hr before this enzyme  treatment,  the commitment to interferon
production  has then been initiated and the enzyme has  no effect  as compared
to controls.
Our  studies  (37)  indicate  that  only  a very  small  percentage  of the  RNA
over  cells  is  bound  to  the  cell  surface,  that  is  1%  or  less.  In  addition,  the
majority  of  this RNA  stays  on  the  surface  of the  cell  during  the  interferon
induction  process,  and only a very small amount actually penetrates  the  cell.
However,  as  the  third  step  (c)  demonstrates,  if  cells  are left  in contact  with
RNA for longer  periods  of time,  there clearly  is degradation  of this  RNA  to
monomeric  units which  would  then  be  utilized  by the  cell  in  its  own RNA
synthesis. This process of utilization  is unessential for the interferon  production
process.  On the other hand,  it is not clear where the critical  step  for trigger-
ing interferon  is.  That is,  whether it is related  to the large amount of polymer
on  the surface  of the cell  or a  small fraction of polymer  taken within the cell.
Table  V  presents  studies  which  followed  cellular  binding  of radioactivity
TABLE  V
INDUCTION  OF  INTERFERON  BY  I:C--REQUIREMENT
FOR  A  TEMPERATURE  DEPENDENT  STEP*
Calculated  approx. number of  I:  C-1H
Interferon  Cell radioactivity  molecules
Time  of  1 hr treatment  Time  of  I  hr treatment  Time of 1 hr treatment
Treatment at 37°C  0  hr  1.5  hr  0 hr  1.5  hr  0  hr  1.5  hr
U/4  ml  cpm/2  X  10O  cells  molecules/cell
RNase  2  68  10  11  5000  5000
None  132  137  420  412  150,000  150,000
* Cells were  exposed  to  I:C-3H  for  I  hr  at 4C, then  washed  6  times  with  minimal  essential
medium  (MEM)  and  treated  at  37°C  as  indicated.  Interferon  production  was  measured  after
11  hr total incubation  at 37°C; cell radioactivity  was determined  immediately after 37°C  treat-
ment.
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and  interferon  production  in parallel,  after the exposure  of human  skin  cells
to tritium-labeled I: C.  In this system the cells were exposed  to the polymer in
the  cold  for  1 hr,  all  unbound  material  then  was  washed  off,  and  the  cells
incubated  at 37C. The  cell  supernatants  were  collected  for interferon  assay
after  10 hr.  In the  absence  of ribonuclease  approximately  130 units  of inter-
feron  were  made,  whereas  no  interferon  was made  with  ribonuclease  treat-
ment immediately after the binding step. However,  if one delays ribonuclease
treatment  1.5  hr,  68  units  of interferon  were  made.  Hence,  during that  1.5
hr, a temperature-dependent  recognition  step occurred.  One can see the fate
of cell  bound radioactivity  during that same  period in  the middle section  of
Table  V.  There  is  30-40-fold  more radioactivity  on  the  surface  of the  cell
than within  the cell-that  is,  150,000  molecular  equivalents  per  cell  on  the
cell  and  no  more  than  5000  molecular  equivalents  within  the  cell.  During
this  1.5  hr period  no increase  in  intracellular  tritium-labeled  I:C  molecules
can be seen.  Hence,  either  some very  small  number  of molecules  enters the
cell  to  interact  with  cytoplasmic  or nuclear  constituents  in the  initiation  of
interferon  production,  or  the  presence  of  the large  amount  of RNA  on  the
surface  of  the cell  at 37°C  is  a critical  factor  in  triggering  the  induction  of
interferon.  To  make  the  system  more  sensitive,  a  higher  specific  activity
material could be used,  and perhaps  then one could  sense  a  critical  increase
in the  intracellular  fraction  of the  RNA  molecule  associated  with interferon
production during  the  1.5 hr at 37C.
To  demonstrate  the  third  stage  of  interaction  of  RNA  with  interferon-
producing  cells,  that is  the  stage  of degradation  and  incorporation  into host
RNA, we adopted a fundamentally  different experimental design.  All studies
on the inducer-cell interaction  described up to now were  based on treatment
of the  cells with a short  pulse of I:C in the cold  and  removal  of extraneous
polymer  before  further treatment.  To  study the  degradation  and  incorpora-
tion,  the  cells  were  continuously  incubated  with  I:C  for  several  hours  at
37C. Here  it was  found  that progressively  more  I:C was  taken  up by  the
fibroblasts and became  resistant  to degradation  by ribonuclease.
In order  to study the intracellular  fate of the cell  associated  I:C,  we per-
formed  radioautography  of  cells  incubated  with  tritium-labeled  I: C  for
various  periods  of  time.  These  studies  indicated  that  this  ribonucleotide
homopolymer pair was degraded in cells and incorporated into cellular RNA.
The radioactivity  was largely  localized over  nucleoli after 3 hr of incubation
of the cells with the tritium-labeled  I: C  as shown in Fig. 3. Radioautographs
at later times showed more grains distributed  over  the nucleoplasm and later
over  the  cytoplasm  as  well.  To  verify  that  the  isotope  in  cells  was  due  to
breakdown  and  reincorporation  into  newly  synthesized  host  RNA,  actino-
mycin and unlabeled cytidine were added. It was observed that this nucleolar
labeling  could  be  completely  blocked.  Here  we  believe  the  I: C  was  stillINTERFERON  INDUCTION.  II
broken down but that the fragments were washed out during the preparation
for radioautography,  as they  could not be incorporated  into  polymeric form.
Since  interferon  was  produced  under  these  conditions,  it  is  clear  the  incor-
poration  of  degraded  I:C  into  cellular  RNA  is  not  required  for  interferon
production,  although  it does  occur  as  a  major  event  in  the  cell  interaction
with  I: C.
FIGURE  3.  Radioautography  of human fibroblasts incubated  with I: C.
ANIMAL  PROTECTION  EXPERIMENTS
Table  VI  presents  a  summary  of  the  animal  virus  challenge  models  from
various  laboratories  which have been  studied  so far  with  I: C  and which  are
most readily related to human disease. Although challenge doses may be much
greater than in man, the route of infection  and pathogenesis  of disease would
seem  to  resemble  the  human  model.  In  all  cases  systemically  administered
I:C is  active  against the virus  challenge  if given  prophylactically  and in  at
least  two models  I:  C is  effective  when  given  after the virus  challenge at the
time  the  virus  is  actively multiplying  in the  target  organ  (51,  53).
Obviously these findings are encouraging  to those who  would like  to study
polynucleotide  inducers  in  human  virus  disease.  However,  another  set  of
findings  must  be  balanced  against  these  positive  findings.  Systemically
administered  I:C,  as  any  other  pharmacologically  active  agent,  has  been
shown to  have  a number  of side  effects  in the  whole  animal.  These include
tumor-necrotizing  effects  (59),  provocation  (but not sensitization)  of the local
Schwartzman  reaction  (60),  pyrogenicity  in  rabbits  (61),  and  embryo-
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toxicity  (62),  all of which resemble effects reported with endotoxin.  Recently,
a picture resembling "runt disease"  has been produced in mice with several
types  of  double-stranded  RNA,  including  I: C. 5 Also,  synthetic  double-
stranded RNA has been shown to potentiate adjuvants and have an adjuvant
effect  in vivo  (63), and to increase  cell-mediated immunity  (64)  and RE cell
activity  (65).6  Whether any of these other in vivo  effects will be limiting for
clinical  studies  or  give  evidence  regarding  the  fundamental  mechanism  of
interferon stimulation by this class  of agents  is only speculative.
TABLE  VI
STUDIES  WITH  POLYANIONIC  INTERFERON  INDUCERS  IN
ANIMAL  MODELS  RELATING  TO  HUMAN  VIRAL  DISEASE
Animal model
Route  Virus  Animal  Human parallel
Intracorneal  Herpes  simplex  Rabbit  (51,  52)*  Herpes  simplex  keratitis
Intramuscular  Rabies  Rabbitt  Rabies  Encephalomyelitis
Intranasal  Vesicular stoma-  Mouse  (53)§  Herpes  or  enterovirus  en-
titis virus  cephalitis
Intranasal  Influenza  Mouse  (6,  54-56)  Influenza
Intranasal  Sendai  Mouse  (55,  56)  Influenza  and other respira-
tory infections
Intranasal  Vaccinia  Mouse  (55)  Smallpox
Intravenous  Vaccinia  Mouse  (2,  5,  6, 56-58)  Smallpox  (Viremic  phase)
Intranasal  Columbia  SK  Mouse  (55,  56)  Polio,  Coxsackie,  and
ECHO infections
* Kaufman,  H. E., E.  D. Ellison,  and  S.  R. Waltman.  1969.  Double  stranded  RNA,  an inter-
feron  inducer,  in herpes  simplex keratitis.  Personal  communication.
T Postic,  B., and P. Fenje.  1970. Prophylaxis  of rabies  in  rabbits  by  poly  I :C. Bacteriol. Proc. 155;
and Janis,  B., and K. Habel.  1970. Polyriboinosinic  and polyribocytidylic acid  polymers  (poly I:C)
in rabies prophylaxis. Fed. Proc. 29:636.
§ De Clercq,  E., M. R. Nuwer, and T. C. Merigan.  1970. The  role  of interferon  in the  protective
effect of a synthetic  double-stranded  polyribonucleotide  against intranasal  vesicular stomatitis virus
challenge  in mice. J.  Clin. Invest. In press.
As preparations  of I:C can  vary one  from another  in terms  of annealing,
and the studies demonstrating side effects have not, in the main,  been carried
out with  studies  of concomitant  interferon induction  or antiviral protection,
we can not directly relate results of antiviral activity and toxicity in different
laboratories.  Accurate therapeutic ratios must be established in animal models
before  we can make predictions  regarding  human  efficacy.  Another  compli-
cation in such predictions is that toxicity of these materials varies widely from
6  Leonard,  B. J., E.  Eccleston,  and D. Jones.  1969.  Toxicity  of interferon  inducers  of the  double
stranded RNA  type. Nature (London).  224:1023.
6Remington,  J.  S.,  and  T.  C.  Merigan.  1970.  Synthetic  polyanions  protect  mice  against  intra-
cellular bacterial  infection.  Nature (London). In  press.
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one animal  species  to another  (56),  and hence,  therapeutic  ratios  must ulti-
mately  be  established  in  man.  Local  rather  than  systemic  approaches  to
therapy,  such  as  can  be  utilized  in  the  skin  and  eye  and  perhaps  in  the
respiratory  tract,  are  obviously  less  complicated,  but  with  macromolecules
like  I:C  there  are  likely  to  be  problems  in  delivery  or  distribution  to  the
diseased area. However, by combining knowledge of the best routes of delivery
and  of  the  timing  of various  effects  of the  inducers  in  animal  models  with
knowledge  of viral infectious  processes  in  any given human disease,  one can
set  up  the most  favorable  approach  to  clinical  prophylaxis  or  therapy.  It
appears that successful  manipulation of host resistance mechanisms in the face
of disease is likely to require greater knowledge of details of the disease process
than chemotherapy with agents which act directly against parasites.
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